
Dry AMD Model
Our Dry AMD model combines blue light and A2E treatment of iPSC-derived RPE cells. Screen small molecule librairies with high-throughput assays. Test and validate your active coumpound with dedicated in vitro bioassays.
Ask a specialist
Send your request to us
View the latest news from us and our suppliers.
Our Dry AMD model combines blue light and A2E treatment of iPSC-derived RPE cells. Screen small molecule librairies with high-throughput assays. Test and validate your active coumpound with dedicated in vitro bioassays.
Coating your own soft hydrogels is expensive, labour-intensive, and impractical. Rather than spending time coating your own hydrogels
Synbio Technologies’ oligo synthesis platform equips state-of-the-art synthesizers and leading professional teams experienced in the oligo synthesis as well as modification technologies.
We have developed the most comprehensive platforms of oligo synthesis, gene synthesis (fragment and clonal genes)and next-generation high-throughput gene synthesis to meet our customers’ needs in quality, speed, budget, and applications.
Our consultants are familiar with the applicable quality standards and can help you design or adapt your quality and safety processes in order to minimize the risks involved in (bio) pharmaceutical production.
Connect With Our Technical Specialist.
Request For A Quotaiton